Scientist Jailed for Gene Hacking Babies Says Ethics Are Holding Back Progress
By Luis Prada,
Vice
| 03. 14. 2025
public domain photo by Voice of America via Wikimedia Commons
Back in 2019, Chinese biophysicist He Jiankui proudly announced to the world that he had created two genetically edited human babies, fully expecting a round of applause and three cheers of “Hip Hip Hooray.” Instead, everyone booed him and he got thrown in prison for three years.
He’s since been released from prison, though it doesn’t seem like he’s learned any lessons from his stint in the clink. This was demonstrated by a post on Twitter/X wherein he accompanied a soulless picture of himself in a tweet in which he says that “ethics is holding back scientific innovation and progress.”
Now, you might recognize that is the kind of thing a villain says before he splices into your DNA, unforeseen consequences be damned. Jiankui used CRISPR gene-editing technology to edit the DNA of a set of twins codenamed “Nana” and “Lulu” to make them immune to HIV. Sounds like a noble goal, until you find out that fiddling with those genes to make the girls immune to HIV could...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Michael Gibney, PharmaVoice | 03.20.2025
The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech innovation.
While gene therapies like Sarepta’s offer an opportunity to treat and...
By Staff, The Medicine Maker | 03.21.2025
"The Promise and Peril of CRISPR" cover by Johns Hopkins University Press
As a paediatrician taking care of children with sickle cell disease, Neal Baer, a Harvard Medical School graduate, was in awe of the power of CRISPR technologies. Later...